CTMX - Wall Street Estimates - CytomX Therapeutics, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 0.84

-0.838 %

$ 65.7 M

Market Cap

5.25

P/E

Price Target Average

420.24%

Revenue Forecast Estimate

--1.88%

EBIT Estimate

--125.64%

Net Income Estimate

--261.77%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets CytomX Therapeutics, Inc.

Wall Street analysts predict an average 1-year price target for CTMX of $4.37 , with forecasts ranging from a low of $2.5 to a high of $8 .

CTMX Lowest Price Target Wall Street Target

2.5 USD 197.62%

CTMX Average Price Target Wall Street Target

4.37 USD 420.24%

CTMX Highest Price Target Wall Street Target

8 USD 852.38%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free